University of California, Irvine: Breast Neoplasms trials
The registry lists 14 Breast Neoplasms studies with University of California, Irvine as lead sponsor. 3 are open to participants now and 4 have results posted.
Phase 2 7No phase 7(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot TrialRecruitingNCT07447050Phase 2
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast CancerRecruitingNCT05524584Phase 2
- Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast CancerTerminatedNCT04305236Phase 2Results posted
- Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant SettingCompletedNCT00618657Phase 2Results posted
- Combined MRI and Optical Imaging to Improved Breast Cancer DiagnosisTerminatedNCT00610467Not applicableResults posted
- Neoadjuvant Treatment of Breast CancerCompletedNCT00254592Phase 2Results posted
- Overall Diet Quality and Breast Cancer RiskCompletedNCT03304171
- Phase II Breast Ca Carboplatin + Paclitaxel With Pertuzumab + Trastuzumab or BevacizumabActive, not recruitingNCT02436993Phase 2
- Breast Tumor Oxygenation During ExerciseWithdrawnNCT02340468
- A Pilot Study of Irinotecan in Patients With Breast Cancer and CNS MetastasesWithdrawnNCT01939483Not applicable
- Predicting Pathological Response Within the 1st Week of Chemotherapy Using Diffuse Optical Spectroscopic ImagingWithdrawnNCT01277263
- Monitoring and Predicting Breast Cancer Neoadjuvant Chemotherapy Response Using Diffuse Optical Spectroscopic ImagingWithdrawnNCT01257932
- Monitoring the Response of Chemotherapy on Breast Cancer Tumor by Photon Migration SpectroscopyCompletedNCT00540852Not applicable